Literature DB >> 31197473

Innate immunity and urinary tract infection.

Christina Ching1,2,3, Laura Schwartz1,2, John David Spencer1,2,4, Brian Becknell5,6,7.   

Abstract

Urinary tract infections are a severe public health problem. The emergence and spread of antimicrobial resistance among uropathogens threaten to further compromise the quality of life and health of people who develop acute and recurrent upper and lower urinary tract infections. The host defense mechanisms that prevent invasive bacterial infection are not entirely delineated. However, recent evidence suggests that versatile innate immune defenses play a key role in shielding the urinary tract from invading uropathogens. Over the last decade, considerable advances have been made in defining the innate mechanisms that maintain immune homeostasis in the kidney and urinary tract. When these innate defenses are compromised or dysregulated, pathogen susceptibility increases. The objective of this review is to provide an overview of how basic science discoveries are elucidating essential innate host defenses in the kidney and urinary tract. In doing so, we highlight how these findings may ultimately translate into the clinic as new biomarkers or therapies for urinary tract infection.

Entities:  

Keywords:  Antimicrobial peptides; Cytokines; Innate immunity; Pattern recognition receptors; Pyelonephritis; Urinary tract infection

Mesh:

Year:  2019        PMID: 31197473      PMCID: PMC6908784          DOI: 10.1007/s00467-019-04269-9

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.651


  72 in total

1.  Lps genotype in the C57 black mouse background and its influence on the interleukin-6 response to E. coli urinary tract infection.

Authors:  W Agace; S Hedges; C Svanborg
Journal:  Scand J Immunol       Date:  1992-05       Impact factor: 3.487

2.  Crosstalk between sentinel and helper macrophages permits neutrophil migration into infected uroepithelium.

Authors:  Marzena Schiwon; Christina Weisheit; Lars Franken; Sebastian Gutweiler; Akanksha Dixit; Catherine Meyer-Schwesinger; Judith-Mira Pohl; Nicholas J Maurice; Stephanie Thiebes; Kristina Lorenz; Thomas Quast; Martin Fuhrmann; Georg Baumgarten; Martin J Lohse; Ghislain Opdenakker; Jürgen Bernhagen; Rick Bucala; Ulf Panzer; Waldemar Kolanus; Hermann-Josef Gröne; Natalio Garbi; Wolfgang Kastenmüller; Percy A Knolle; Christian Kurts; Daniel R Engel
Journal:  Cell       Date:  2014-01-30       Impact factor: 41.582

3.  The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney.

Authors:  H Kulaksiz; F Theilig; S Bachmann; S G Gehrke; D Rost; A Janetzko; Y Cetin; W Stremmel
Journal:  J Endocrinol       Date:  2005-02       Impact factor: 4.286

4.  Characterization of the mouse beta defensin 1, Defb1, mutant mouse model.

Authors:  Gillian Morrison; Fiona Kilanowski; Donald Davidson; Julia Dorin
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

5.  CD14- and Toll-like receptor-dependent activation of bladder epithelial cells by lipopolysaccharide and type 1 piliated Escherichia coli.

Authors:  Joel D Schilling; Steven M Martin; David A Hunstad; Kunal P Patel; Matthew A Mulvey; Sheryl S Justice; Robin G Lorenz; Scott J Hultgren
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

Review 6.  TLR- and CXCR1-dependent innate immunity: insights into the genetics of urinary tract infections.

Authors:  B Ragnarsdóttir; H Fischer; G Godaly; J Grönberg-Hernandez; M Gustafsson; D Karpman; A C Lundstedt; N Lutay; S Rämisch; M L Svensson; B Wullt; M Yadav; C Svanborg
Journal:  Eur J Clin Invest       Date:  2008-10       Impact factor: 4.686

7.  Pathogen specific, IRF3-dependent signaling and innate resistance to human kidney infection.

Authors:  Hans Fischer; Nataliya Lutay; Bryndís Ragnarsdóttir; Manisha Yadav; Klas Jönsson; Alexander Urbano; Ahmed Al Hadad; Sebastian Rämisch; Petter Storm; Ulrich Dobrindt; Ellaine Salvador; Diana Karpman; Ulf Jodal; Catharina Svanborg
Journal:  PLoS Pathog       Date:  2010-09-23       Impact factor: 6.823

8.  IRF7 inhibition prevents destructive innate immunity-A target for nonantibiotic therapy of bacterial infections.

Authors:  Manoj Puthia; Ines Ambite; Caterina Cafaro; Daniel Butler; Yujing Huang; Nataliya Lutay; Gustav Rydström; Birgitta Gullstrand; Bhairavi Swaminathan; Aftab Nadeem; Björn Nilsson; Catharina Svanborg
Journal:  Sci Transl Med       Date:  2016-04-27       Impact factor: 17.956

9.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

Review 10.  Antimicrobial Peptides: An Emerging Category of Therapeutic Agents.

Authors:  Margit Mahlapuu; Joakim Håkansson; Lovisa Ringstad; Camilla Björn
Journal:  Front Cell Infect Microbiol       Date:  2016-12-27       Impact factor: 5.293

View more
  8 in total

1.  Impact of successful pediatric ureteropelvic junction obstruction surgery on urinary HIP/PAP and BD-1 levels.

Authors:  Sudipti Gupta; Lauren Nicassio; Guillermo Yepes Junquera; Ashley R Jackson; Molly Fuchs; Daryl McLeod; Seth Alpert; Venkata R Jayanthi; Daniel DaJusta; Kirk M McHugh; Brian Becknell; Christina B Ching
Journal:  J Pediatr Urol       Date:  2020-03-29       Impact factor: 1.830

Review 2.  Timing is everything: impact of development, ageing and circadian rhythm on macrophage functions in urinary tract infections.

Authors:  Alison S Wang; Nicholas J Steers; Adwaita R Parab; Frédéric Gachon; Matthew J Sweet; Indira U Mysorekar
Journal:  Mucosal Immunol       Date:  2022-08-29       Impact factor: 8.701

3.  Expression and function of human ribonuclease 4 in the kidney and urinary tract.

Authors:  Kristin Bender; Laura L Schwartz; Ariel Cohen; Claudia Mosquera Vasquez; Matthew J Murtha; Tad Eichler; Jason P Thomas; Ashley Jackson; John David Spencer
Journal:  Am J Physiol Renal Physiol       Date:  2021-04-05

Review 4.  The Responses of the Ribonuclease A Superfamily to Urinary Tract Infection.

Authors:  Brian Becknell; Christina Ching; John David Spencer
Journal:  Front Immunol       Date:  2019-11-29       Impact factor: 7.561

5.  MicroRNA-30e-5p Regulates SOCS1 and SOCS3 During Bacterial Infection.

Authors:  Richa Mishra; Pandikannan Krishnamoorthy; Himanshu Kumar
Journal:  Front Cell Infect Microbiol       Date:  2021-01-27       Impact factor: 5.293

6.  A Systematic Review of the (Un)known Host Immune Response Biomarkers for Predicting Recurrence of Urinary Tract Infection.

Authors:  Iva Sorić Hosman; Andrea Cvitković Roić; Lovro Lamot
Journal:  Front Med (Lausanne)       Date:  2022-07-04

7.  Risk Factors of Urinary Pathogenic Bacteria Infection after Benign Prostatic Hyperplasia Surgery and Curative Effect Analysis of Shuangdong Capsule Intervention.

Authors:  Bing Xu; Ming Liu; Yonghui Liu; Jianhong Zuo
Journal:  Emerg Med Int       Date:  2022-09-08       Impact factor: 1.621

8.  A Synthetic Peptide 2Abz23S29 Reduces Bacterial Titer and Induces Pro-Inflammatory Cytokines in a Murine Model of Urinary Tract Infection.

Authors:  Neda Moazzezy; Mohammad Reza Asadi Karam; Sima Rafati; Saeid Bouzari; Mana Oloomi
Journal:  Drug Des Devel Ther       Date:  2020-07-17       Impact factor: 4.162

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.